Maximillian Zinner

Maximillian Zinner

Auto-generated profile, based on publicly available information

Maximillian Zinner

Faculty of Health, School of Medicine, Witten/Herdecke University, Alfred-Herrhausen-Strasse 50, Witten, 58455, Germany, 49 202 8963708

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
FDFlorian Dahlhausen
Florian Dahlhausen
MZMaximillian Zinner
Maximillian Zinner
LBLinn Bieske
Linn Bieske
Jan P. EhlersJan P. Ehlers
Jan P. Ehlers
PBPhilip Boehme
Philip Boehme
LFLeonard Fehring
Leonard Fehring
Background: In October 2020, Germany became the first country, worldwide, to approve certain mobile health (mHealth) apps, referred to as DiGA (Digitale Gesundheitsanwendungen, in German, meaning digital health applications), for prescription with costs covered by standard statutory health insurance. Yet, this option has only been used to a limited extent so far. Objective: The aim of this study was to investigate physicians’ and psychotherapists’ current attitudes toward mHealth apps, barriers to adoption, and potential remedies. Methods: We conducted a two-stage sequential mixed methods study. In phase one, semistructured interviews were conducted with physicians and psychotherapists for questionnaire design. In phase two, an online survey was conducted among general practitioners, physicians, and psychotherapists. Results: A total of 1308 survey responses by mostly outpatient-care general practitioners, physicians, and psychotherapists from across Germany who could prescribe DiGA were recorded, making this the largest study on mHealth prescriptions to date. A total of 62.1% (807/1299) of respondents supported the opportunity to prescribe DiGA. Improved adherence (997/1294, 77.0%), health literacy (842/1294, 65.1%), and disease management (783/1294, 60.5%) were most frequently seen as benefits of DiGA. However, only 30.3% (393/1299) of respondents planned to prescribe DiGA, varying greatly by medical specialty. Professionals are still facing substantial barriers, such as insufficient information (1135/1295, 87.6%), reimbursement for DiGA-related medical services (716/1299, 55.1%), medical evidence (712/1298, 54.9%), legal uncertainties (680/1299, 52.3%), and technological uncertainties (658/1299, 50.7%). To support professionals who are unsure of prescribing DiGA, extended information campaigns (1104/1297, 85.1%) as well as recommendations from medical associations (1041/1297, 80.3%) and medical colleagues (1024/1297, 79.0%) were seen as the most impactful remedies. Conclusions: To realize the benefits from DiGA through increased adoption, additional information sharing about DiGA from trusted bodies, reimbursement for DiGA-related medical services, and further medical evidence are recommended.

1 July 2021 in Drug Discovery Today
Verified
Journal Article
Closed access
MZMaximillian Zinner
Maximillian Zinner
FDFlorian Dahlhausen
Florian Dahlhausen
PBPhilip Boehme
Philip Boehme
JEJan Ehlers
Jan Ehlers
LBLinn Bieske
Linn Bieske
LFLeonard Fehring
Leonard Fehring

1 February 2022 in Drug Discovery Today
Verified
Journal Article
Closed access
MZMaximillian Zinner
Maximillian Zinner
FDFlorian Dahlhausen
Florian Dahlhausen
PBPhilip Boehme
Philip Boehme
JEJan Ehlers
Jan Ehlers
LBLinn Bieske
Linn Bieske
LFLeonard Fehring
Leonard Fehring


3 April 2023 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
AGAlexander Graf
Alexander Graf
LFLeonard Fehring
Leonard Fehring
MHMaike Henningsen
Maike Henningsen
MZMaximillian Zinner
Maximillian Zinner

5 May 2025 in JMIR Human Factors
Verified
Journal Article
Open access
BSBenedict Sevov
Benedict Sevov
RHRobin Huettemann
Robin Huettemann
MZMaximillian Zinner
Maximillian Zinner
Sven MeisterSven Meister
Sven Meister
LFLeonard Fehring
Leonard Fehring
Background: Mental health issues represent a prevalent challenge for employees and their employers, leading to substantial impacts on individuals, society, and the economy. Different employee mental health programs (EMHPs) can support employees in preventing and treating mental health issues. However, the impact of such EMHPs depends largely on the use behavior of employees. Objective: This study aimed to gain deeper insights into employees’ attitude and use behavior regarding EMHPs by investigating (1) employee preference and intention to use EMHPs, (2) factors that predict use, and (3) key facilitators and barriers influencing use. Methods: An exploratory sequential mixed methods approach was applied, including a scoping review, qualitative interviews, and a quantitative web-based survey. Semistructured qualitative interviews were conducted with 15 employees to gain insights into EMHPs from the employee perspective and inform the creation of a web-based questionnaire. The quantitative web-based survey was conducted to collect representative primary data on employees’ perspectives on different EMHPs using 7-point Likert scales. The collected quantitative data were analyzed through descriptive and inferential statistics, including repeated measures ANOVAs and chi-square tests. Results: The final sample of the web-based survey consisted of 1134 participants and was representative across several sociodemographic characteristics. Analysis of the sample revealed that when given the choice, employees preferred digital (n=666, 58.73%) and self-intervention (n=590, 52.03%) EMHPs. Employees were most likely to use EMHPs focused on prevention (mean 4.89, SD 1.61). Intention to use EMHPs was predicted by age (young: mean 4.59, SD 1.2; old: mean 4.19, SD 1.4; P<.001; Cohen d=0.32), education (academic degree: mean 4.68, SD 1.24; no academic degree: mean 4.26, SD 1.32; P<.001; Cohen d=0.32), and mostly by company culture (positive company culture: mean 4.61, SD 1.27; negative company culture: mean 3.99, SD 1.27; P<.001; Cohen d=0.49). Cost coverage (n=345, 30.42%) and ease of use (n=337, 29.72%) were critical facilitators of use. Conclusions: Employers can have a positive contribution to employee mental health by starting to offer EMHPs, preferably digital self-intervention programs for prevention; creating and maintaining the right work environment and culture; and ensuring cost coverage for the EMHP.